TrialStem cells translational medicine2022

Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis.

Panayiota Petrou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.